Showing results (211-220 of 376) with videos related to
Sort By:
Pageof 38
The British Journal of Ophthalmology|November 26, 2002
Anti-inflammatory fibrosis suppression in threatened trabeculectomy bleb failure produces good long term control of intraocular pressure without risk of sight threatening complicationsJ R Fuller, T H Bevin, A C B Molteno, et al.Journal of the American Society for Mass Spectrometry|December 16, 2014
On the split personality of penultimate prolineMatthew S Glover, Liuqing Shi, Daniel R Fuller, et al.Biology|November 27, 2025
Characterising PMP22-Proximal Partners in a Schwann Cell Model of Charcot-Marie-Tooth Disease Type1AIan Holt, Nicholas Emery, Monte A Gates, et al.Biorxiv : the Preprint Server for Biology|January 13, 2025
Structural basis of directionality control in large serine integrasesHeewhan Shin, Ying Pigli, Tania Peña Reyes, et al.Analytical Chemistry|April 15, 2004
Characterization of the physicochemical parameters of dense core atrial gland and lucent red hemiduct vesicles in Aplysia californicaLuisa Ciobanu, Stanislav S Rubakhin, Jeffrey N Stuart, et al.Optics Express|March 5, 2009
Cellular resolution volumetric in vivo retinal imaging with adaptive optics-optical coherence tomographyRobert J Zawadzki, Stacey S Choi, Alfred R Fuller, et al.Blood|January 1, 1977
Cytofluorometric analysis of the kinetics of lymphocyte transformation after phytohemagglutinin stimulation: comparison with the kinetics of thymidine incorporationP D Utsinger, W J Yount, J G Fallon, et al.Journal of the American Society for Mass Spectrometry|May 8, 2016
Cis→Trans Isomerization of Pro(7) in Oxytocin Regulates Zn(2+) BindingDaniel R Fuller, Matthew S Glover, Nicholas A Pierson, et al.Journal of the American Society for Mass Spectrometry|April 14, 2019
Substance P in the Gas Phase: Conformational Changes and Dissociations Induced by Collisional Activation in a Drift TubeChristopher R Conant, Daniel R Fuller, Zhichao Zhang, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 15, 2001
Metabolism of vanoxerine, 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine, by human cytochrome P450 enzymesS A Cherstniakova, D Bi, D R Fuller, et al.Pageof 38